Aurobindo Pharma Q3 PAT at Rs 55.25 cr

Published on Wed, Jan 30, 2008 at 13:31 |  Source : Moneycontrol.com

Updated at Wed, Jan 30, 2008 at 14:55  

18211 Investors following Aurobindo Pharm. Share this News with them.
0
0
Share on Tumblr

Aurobindo Pharma has announced its third quarter results. The company's Q3 standalone net sales were at Rs 510.8 crore (Rs 5.10 billion) versus Rs 528.4 crore (Rs 5.28 billion), YoY.

Its standalone net profit was at Rs 55.25 crore (Rs 552.5 million) versus Rs 60.12 crore (Rs 601.2 million), YoY.

Result (Rs cr) Dec-07 Sep-07 Jun-07 Mar-06 Dec-06
Net Sales / Interest Earned / Operating Income 511 612 480 533 528
Other Income 39 38 33 15 26
Total Income 549 649 513 548 555
Expenditure -456 -504 -426 -468 -450
Operating Profit 94 145 87 80 105
Interest -3 -4 -4 -3 -20
Profit Before Depreciation and Tax 90 141 82 77 85
Depreciation -19 -19 -17 -26 -16
Profit before Tax 71 122 65 51 69
Tax -16 -22 -7 27 -9
Net Profit 55 101 59 78 60
Equity Capital 27 27 - 27 27

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com